The Prince Edward Island BioAlliance and Neurodyn will present the 4th Annual Biotechnology & Human Health Symposium, July 7- 9, 2013 at Rodd’s Brudenell River Resort, Prince Edward Island. The symposium will provide delegates insight into how inflammatory processes play an important role in the development of many neurological disease conditions and represent key therapeutic targets.
The Biotechnology & Human Health Symposium program annually attracts international pharmaceutical companies, early stage companies, medical practitioners, principal investigators in clinical trials, contract research organizations, and investors who are focused on this therapeutic area.
Dr. Jackalina Van Kampen, Director of Preclinical Research at Neurodyn Inc. and Adjunct Professor, Department of Biomedical Sciences at UPEI, is Program Chair of the Biotechnology and Human Health Symposium. She says the event will be one of the best yet. “This is shaping up to be a very exciting meeting. The concentration of talent that will be gathered here in PEI will give attendees access to some of the world leaders in our field of neurological research. We are very fortunate to attract speakers renowned in this area of research and I’m very proud to be a part of it.”
This year’s event is being made possible with financial assistance of from the Government of Canada, through the Atlantic Canada Opportunities Agency (ACOA).
“I am proud of our Government’s continued support for Atlantic Canada’s innovative bioscience sector. These investments help to build our region’s commercialization capacity and strengthen our economy,” said the Honourable Gail Shea, Minister of National Revenue and Minister for ACOA. “I encourage all attending delegates from Canada and around the world to have meaningful discussions and build strong relationships during the 4th Annual Biotechnology and Human Health Symposium.”
This year’s program will feature a pre-symposium public lecture with Dr. Patrick McGeer from the University of British Columbia who will present “How to maintain a healthy brain and avoid dementia” on the evening of July 7th at 7:00 pm in Brudenell.
The main program on July 8th and 9th will feature 12 leading researchers from across North America, Europe, Israel, and India who will present and discuss the role of neuro-inflammation and autoimmunity in the pathogenesis of neurological disease and the process of translating basic research into clinical practice.
Canadian researchers and companies, such as Neurodyn, are doing important work in the areas of neurological disease prevention and therapy development. This Symposium gives local industry the opportunity to showcase the quality of work taking place in Atlantic Canada and provides key connections for industry representatives, as well as providing the general public with beneficial information on research, discoveries, and preventative measures for neurodegenerative diseases affecting Islanders.
Organizers have also invited international pharmaceutical organizations, such as Johnson and Johnson and Genzyme, as well as local early stage companies, including Delivra, Neurodyn, and Vitrak Systems Inc., and contract research organizations such as Advinus to present on their therapeutic focus and priorities.
An important part of the program will be the One-to-One Business Partnering Program where participants will discuss their research, clinical experience, therapeutics and areas of focus and new business opportunities.
For more information and to register, visit www.biotechnologyandhumanhealth.com.
About Neurodyn
Neurodyn Inc. is a Canadian biotechnology company identifying, validating and developing natural products to support brain health. The company has developed its BioActives Discovery Engine™ through a combination of international partners with demonstrated historical knowledge of natural compounds, in-house medicinal chemistry capability, and proprietary neurological models. Neurodyn is using this powerful engine for its Rx and natural product development programs, including their recently launched NeuroPro™ supplement. NeuroPro has been formulated for individuals requiring cognitive, mental and physical support as they age.
About the PEI BioAlliance
The PEI BioAlliance is the not-for-profit organization dedicated to building the Bioscience sector in Prince Edward Island through collaborative efforts with industry, government, academia, and research organizations. The PEI Bioscience Cluster currently represents 38 companies generating over $100 million in private sector revenues. The local industry employs more than 1,000 public and private sector employees.
FOR MORE INFORMATION:
Jennifer Lenentine
Manager, Corporate Services
Prince Edward Island BIoAlliance
(902) 367-4400/Jennifer@peibioalliance.com